Dynamic Technology Lab Private Ltd Takes $470,000 Position in ZimVie Inc. (NASDAQ:ZIMV)

Dynamic Technology Lab Private Ltd bought a new position in shares of ZimVie Inc. (NASDAQ:ZIMV) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 29,601 shares of the company’s stock, valued at approximately $470,000. Dynamic Technology Lab Private Ltd owned 0.11% of ZimVie as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its stake in ZimVie by 6.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock worth $356,000 after buying an additional 1,275 shares during the period. Quarry LP increased its stake in ZimVie by 337.8% during the 2nd quarter. Quarry LP now owns 1,655 shares of the company’s stock worth $30,000 after buying an additional 1,277 shares during the period. Summit Securities Group LLC increased its stake in ZimVie by 518.6% during the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company’s stock worth $55,000 after buying an additional 2,515 shares during the period. Rhumbline Advisers increased its stake in ZimVie by 6.6% during the 2nd quarter. Rhumbline Advisers now owns 44,699 shares of the company’s stock worth $816,000 after buying an additional 2,760 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in ZimVie by 3.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 102,431 shares of the company’s stock worth $1,869,000 after buying an additional 3,441 shares during the period. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Trading Up 1.6 %

NASDAQ ZIMV opened at $14.76 on Friday. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 52 week low of $9.31 and a 52 week high of $22.40. The stock has a market capitalization of $407.38 million, a PE ratio of -1.12 and a beta of 2.14. The firm has a 50 day moving average of $14.70 and a two-hundred day moving average of $16.58.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC upped their target price on shares of ZimVie from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Friday, August 2nd.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.